MedPath

Feasibility study of UFT/LV as adjuvant chemotherapy for stage III colorectal cancer in elderly patients (over 80 years old)

Phase 2
Recruiting
Conditions
Colorectal cancer
Registration Number
JPRN-UMIN000011899
Lead Sponsor
Hiroshima Study group of Clinical Oncology (HiSCO)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

1.History of serious drug hypersensitivity 2.Wattery diarrhea 3.Cases with severe postoperative complication 4.Males with female partners who are planning to pregnancy 5.Severe comorbidity 6.Synchronous or metachronous multiple malignancy within the last 5 year disease free interval 7.Any other serious or uncontrolled condition which, in the opinion of the investigator, makes it undesirable for the patient to enter the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility
Secondary Outcome Measures
NameTimeMethod
Safety, Overall survival, Disease free survival, Relative Dose Intensity
© Copyright 2025. All Rights Reserved by MedPath